Keywords: cinryze, achieves, min, symptom, improvement, drugmaker, viropharma

Cinryze achieves 30 min symptom improvement

Article | 01 December 2008

Print This

US drugmaker ViroPharma presented strong data from an ongoing, open-label study of Cinryze (human C1 inhibitor) showing that it has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in